Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06508164 · ClinicalTrials.gov registry record

International CRDS Registry

A clinical trial of Calcium Release Deficiency Syndrome, sponsored by Population Health Research Institute.

Recruiting
Registry status
500
Enrollment target
16
Study locations

NCT06508164 is a study of Calcium Release Deficiency Syndrome that is actively recruiting participants, run by Population Health Research Institute. The registered enrollment target is 500 participants. The trial reports 16 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06508164, a study of Calcium Release Deficiency Syndrome, is actively recruiting participants, sponsored by Population Health Research Institute.

RECRUITING
Registry status
500 participants
Enrollment target
16
Study locations

Study Summary

Calcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, including its phenotypic spectrum, approaches to risk stratification, and optimal treatment strategies.

Study Locations (16)

Other

  • Universitair Ziekenhuis Brussel - Brussels
  • Aarhus University Hospital - Aarhus
  • Shaare Zedek Medical Center - Jerusalem
  • City St George's, University of London - London

Ontario

  • Hamilton General Hospital - Hamilton
  • London Health Sciences Centre - University Hospital - London

Quebec

  • Montréal Heart Institute - Montreal
  • Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval - Québec

California

  • University of California - San Francisco

Minnesota

  • Mayo Clinic - Rochester

North Carolina

  • Duke University - Durham

New South Wales

  • Garvan Institute of Medical Research - Darlinghurst

Antwerp

  • Antwerp University Hospital - Edegem

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-11-21
Est. Completion 2050-12-31

What the Registry Record Tells You About NCT06508164

The ClinicalTrials.gov registry entry for NCT06508164 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Population Health Research Institute, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Calcium Release Deficiency Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT06508164 reports 16 study locations spanning 11 distinct geographic areas - top geographies include Other, Ontario, Quebec.

Frequently Asked Questions

What is clinical trial NCT06508164 about?

NCT06508164 is a clinical study titled "International CRDS Registry". Calcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, including its phenotypi...

What is the current status of trial NCT06508164?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-11-21. Estimated completion is 2050-12-31.

What conditions does trial NCT06508164 study?

This clinical trial studies the following conditions: Calcium Release Deficiency Syndrome.

Who is sponsoring clinical trial NCT06508164?

This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06508164 being conducted?

This trial has 16 study locations across California, Minnesota, North Carolina, New South Wales, Antwerp. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.